Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease

Blood

Volumn 96, Issue 9, 2000, Pages 3276-3278

  Styles, L A ^a   Aarsman, A J ^a   Vichinsky, E P ^a   Kuypers, F A ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME BLOOD LEVEL; FEVER; HUMAN; INFLAMMATION; PREDICTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THORAX DISEASE;

EID: 0034329363     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.3276.h8003276_3276_3278     Document Type: Article

References (19)

1. Mortality in sickle cell disease: Life expectancy and risk factors for early death
2. Acute chest syndrome in children with sickle cell disease
3. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality
4. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
5. Pathogenesis of lung disease in the sickle hemoglobinopathies
6. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia
7. +-thalassemia
8. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: Is it accurate enough?
9. Acute chest syndrome in sickle cell disease: Clinical presentation and course
10. Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF)
11. Elevated plasma phospholipase A2 levels: Correlation with the hemodynamic and pulmonary changes in gram-negative septic shock
12. Eicosanoids and lung inflammation
13. Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases
14. Phospholipase A2 levels in acute chest syndrome of sickle cell disease
15. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group
16. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA
17. Characterization of phospholipase A2 activities in sera of patients suffering from inflammatory diseases
18. A fluorescence-based assay for human type II phospholipase A2
19. Effects of a long-term transfusion regimen on sickle cell-related illnesses